China's self-developed lung cancer drug available nationwide - Xinhua
Source: Xinhua| Editor: huaxia Video PlayerClose HANGZHOU, Dec. 17 (Xinhua) -- Ensartinib hydrochloride, a targeted drug for lung cancer developed by a Chinese firm, has been available in hospitals and pharmacies nationwide since Wednesday, according to its developer Beta Pharma. The Guangzhou-based Sun Yat-sen University Cancer Center prescribed the medication on Wednesday, first in China. Lung cancer is Chinas leading cause of mortality and morbidity in malignant tumor diseases, among which a...
Beta Pharma Xinhua Ensartinib Sun Yan Chinese Academy Of Engineering Sun Yat Sen University Cancer Center Anaplastic Lymphoma Kinase
Source: xinhuanet.com